Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00633334 · ClinicalTrials.gov registry record
Development of Early Detection Signs for Gastrointestinal Cancer
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 2,499
- Enrollment target
NCT00633334: Completed study, sponsored by University of Pittsburgh.
NCT00633334 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,499 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00633334 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 2,499 participants
- Enrollment target
Study Summary
Therapies involving the immune system have already shown great promise in early clinical trials for the treatment of renal cell carcinoma and melanoma. One of the great challenges now facing this field is to extend these findings to other cancers. Little is currently understood about the nature of the immune response to more common gastrointestinal cancers. The first goal of this proposal is to collect blood and tissue samples from patients with early or late stage gastrointestinal cancers. These samples will be evaluated to better understand the immune response to these two cancers. The second goal of this proposal is to evaluate the specimens of these patients for changes and genetic markers that correlate with the presence of cancer. The information gathered from these studies will directly enhance our ability to design, conduct and monitor novel immunotherapeutic protocols for the treatment of patients with gastrointestinal cancer.
Interventions
- OTHER Specimen bank
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,499 participants |
| Start Date | 2003-09 |
| Est. Completion | 2016-02-17 |
What the finished NCT00633334 record still lists
NCT00633334 is an observational study that tracks outcomes without assigning an intervention. Its 2,499 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Specimen bank is the first listed.
NCT00633334 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00633334 about?
NCT00633334 is a clinical study titled "Development of Early Detection Signs for Gastrointestinal Cancer". Therapies involving the immune system have already shown great promise in early clinical trials for the treatment of renal cell carcinoma and melanoma. One of the great challenges now facing this field is to extend these findings to other cancers. Little is currently understood about the nature of t...
What is the current status of trial NCT00633334?
This trial is currently completed. The enrollment target is 2,499 participants. The study started on 2003-09. Estimated completion is 2016-02-17.
What interventions are being tested in trial NCT00633334?
The interventions under investigation include: Specimen bank (OTHER).
Who is sponsoring clinical trial NCT00633334?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
- NCT02530658 · 2,500 participants
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia